Bicycle Therapeutics

About:

Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.

Website: http://www.bicycletherapeutics.com

Twitter/X: bicycle_tx

Top Investors: Hercules Capital, Cambridge Innovation Capital, RA Capital Management, Venture Kick, Innovate UK

Description:

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Total Funding Amount:

$1.1B

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2009-01-01

Contact Email:

info(AT)bicycletherapeutics.com

Founders:

Christian Heinis, Gregory Winter

Number of Employees:

101-250

Last Funding Date:

2024-05-23

IPO Status:

Public

© 2025 bioDAO.ai